Boynton; Alton L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Boynton; Alton L..The latest application filed is for "therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis".

Company Profile

0.18.18

Boynton; Alton L. - Redmond WA
Boynton; Alton L. - Kingston WA US
Boynton; Alton L. - Andover KS
Boynton; Alton L. - Bethesda MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis Grant 9,566,294 - Murphy , et al. February 14, 2	2017-02-14
Therapeutic And Diagnostic Applications Based On The Role Of The Cxcr-4 Gene In Tumorigenesis App 20140072564 - Murphy; Gerald P. ; et al.	2014-03-13
Tangential flow filtration devices and methods for leukocyte enrichment Grant 8,518,636 - Bosch , et al. August 27, 2	2013-08-27
Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis Grant 8,409,566 - Murphy , et al. April 2, 2	2013-04-02
Isolation And/or Preservation Of Dendritic Cells For Prostate Cancer Immunotherapy App 20130017600 - Murphy; Gerald P. ; et al.	2013-01-17
Compositions And Methods For Inducing The Activation Of Immature Monocytic Dendritic Cells App 20120244620 - Boynton; Alton L. ; et al.	2012-09-27
Connexin Enhances Chemotherapy-included Apoptosis In Human Cancer Cells Inhibiting Tumor Cell Proliferation App 20120045501 - Huang; Ruo-Pan ; et al.	2012-02-23
Tangential Flow Filtration Devices And Methods For Leukocyte Enrichment App 20110189150 - Bosch; Marnix L. ; et al.	2011-08-04
Tangential flow filtration devices and methods for stem cell enrichment Grant 7,790,039 - Bosch , et al. September 7, 2	2010-09-07
Tangential flow filtration devices and methods for leukocyte enrichment Grant 7,695,627 - Bosch , et al. April 13, 2	2010-04-13
Therapeutic And Diagnostic Applications Based On The Role Of The Cxcr-4 Gene In Tumorigenesis App 20100062003 - MURPHY; GERALD P. ; et al.	2010-03-11
Monoclonal antibody specific for the extracellular domain of prostate specific membrane antigen Grant 7,476,513 - Murphy , et al. January 13, 2	2009-01-13
Compositions and Methods for Inducing the Activation of Immature Monocytic Dendritic Cells App 20080254537 - Boynton; Alton L. ; et al.	2008-10-16
Connexin Enhances Chemotherapy-induced Apoptosis In Human Cancer Cells Inhibiting Tumor Cell Proliferation App 20080138337 - Huang; Ruo-Pan ; et al.	2008-06-12
Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen Grant 7,381,407 - Murphy , et al. June 3, 2	2008-06-03
Monoclonal antibody specific for the extracellular domain of prostate specific membrane antigen App 20070128671 - Murphy; Gerald P. ; et al.	2007-06-07
Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen Grant 7,201,900 - Murphy , et al. April 10, 2	2007-04-10
Nr-CAM gene, nucleic acids and nucleic acid products for therapeutic and diagnostic uses for tumors Grant 7,160,868 - Murphy , et al. January 9, 2	2007-01-09
Nr-cam Gene, Nucleic Acids And Nucleic Acid Products For Therapeutic And Diagnostic Uses For Tumors App 20070004655 - MURPHY; GERALD P. ; et al.	2007-01-04
Nr-CAM gene, nucleic acids and nucleic acid products for therapeutic and diagnostic uses for tumors App 20060269558 - Murphy; Gerald P. ; et al.	2006-11-30
Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen Grant 6,962,981 - Murphy , et al. November 8, 2	2005-11-08
Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis App 20050202019 - Murphy, Gerald P. ; et al.	2005-09-15
Tangential flow filtration devices and methods for stem cell enrichment App 20050189297 - Bosch, Marnix L. ; et al.	2005-09-01
Tangential flow filtration devices and methods for leukocyte enrichment App 20050173315 - Bosch, Marnix L ; et al.	2005-08-11
Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis Grant 6,863,887 - Murphy , et al. March 8, 2	2005-03-08
Nr-cam Gene, Nucleic Acids And Nucleic Acid Products For Therapeutic And Diagnostic Uses For Tumors App 20040224909 - MURPHY, GERALD P. ; et al.	2004-11-11
Connexin enhances chemotherapy-induced apoptiosis in human cancer cells inhibiting tumor cell proliferation App 20040180846 - Huang, Ruo-Pan ; et al.	2004-09-16
Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen App 20040024188 - Murphy, Gerald P. ; et al.	2004-02-05
Non-invasive method to detect prostate cancer Grant 6,383,759 - Murphy , et al. May 7, 2	2002-05-07
Non-invasive methods to detect prostate cancer Grant 6,200,765 - Murphy , et al. March 13, 2	2001-03-13
Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen Grant 6,150,508 - Murphy , et al. November 21, 2	2000-11-21
Nucleotide and amino acid sequences of a D2-2 gene associated with brain tumors and methods based thereon Grant 5,874,290 - Murphy , et al. February 23, 1	1999-02-23
Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy Grant 5,788,963 - Murphy , et al. August 4, 1	1998-08-04

Company Registrations

SEC

0001253935

BOYNTON ALTON L

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.